OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
Sun-Young Jung, You Jeong Heo, Sehhoon Park
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006454-e006454
Open Access | Times Cited: 40
Sun-Young Jung, You Jeong Heo, Sehhoon Park
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006454-e006454
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Molecular characteristics of early-onset compared with late-onset colorectal cancer: A case controlled study
Junwei Tang, Wen Peng, Chuanxing Tian, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Junwei Tang, Wen Peng, Chuanxing Tian, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells
Haoxian Ke, Peisi Li, Z. Y. Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Haoxian Ke, Peisi Li, Z. Y. Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
Giorgio Frega, Fernando P. Cossío, Jesús M. Bañales, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2098-2098
Open Access | Times Cited: 19
Giorgio Frega, Fernando P. Cossío, Jesús M. Bañales, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2098-2098
Open Access | Times Cited: 19
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma
Margaret Wheless, Rajiv Agarwal, Laura W. Goff, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 1, pp. 127-160
Open Access | Times Cited: 7
Margaret Wheless, Rajiv Agarwal, Laura W. Goff, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 1, pp. 127-160
Open Access | Times Cited: 7
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection
Elena Brozos-Vázquez, Marta Toledano‐Fonseca, Nicolás Costa‐Fraga, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102719-102719
Open Access | Times Cited: 7
Elena Brozos-Vázquez, Marta Toledano‐Fonseca, Nicolás Costa‐Fraga, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102719-102719
Open Access | Times Cited: 7
Tumor mutational burden in colorectal cancer: Implications for treatment
A. M. Marques, Patrícia Cavaco, Carla Torre, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104342-104342
Open Access | Times Cited: 6
A. M. Marques, Patrícia Cavaco, Carla Torre, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104342-104342
Open Access | Times Cited: 6
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status
Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1825-1825
Open Access | Times Cited: 5
Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1825-1825
Open Access | Times Cited: 5
Retrieval Augmented Therapy Suggestion for Molecular Tumor Boards (Preprint)
Eliza Berman, Holly Sundberg Malek, Michael Bitzer, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e64364-e64364
Open Access
Eliza Berman, Holly Sundberg Malek, Michael Bitzer, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e64364-e64364
Open Access
Subtype-Specific Patterns of Tumor Purity and Mutation Load Suggest Treatment Implications
Daniel Schneider, Ethan Brown, Jacob Gluski, et al.
American Journal of Clinical Oncology (2025)
Closed Access
Daniel Schneider, Ethan Brown, Jacob Gluski, et al.
American Journal of Clinical Oncology (2025)
Closed Access
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report
Hailing Yu, Tan Deng, Hongbing Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Hailing Yu, Tan Deng, Hongbing Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Vittore Cereda, Mario D’Andrea
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Vittore Cereda, Mario D’Andrea
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Genomic Landscape and Clinical Impact of Homologous Recombination Repair Gene Mutation in Small Bowel Adenocarcinoma
Toshiki Ozato, Yoshiyasu Kono, Shigeru Horiguchi, et al.
European Journal of Cancer (2025), pp. 115401-115401
Closed Access
Toshiki Ozato, Yoshiyasu Kono, Shigeru Horiguchi, et al.
European Journal of Cancer (2025), pp. 115401-115401
Closed Access
The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes
Federica Torricelli, Filomena Spada, Cynthia Bishop, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Federica Torricelli, Filomena Spada, Cynthia Bishop, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Combined Immune Checkpoint Blockade and Helixor® Therapy in Oncology: Real-World Tolerability and Subgroup Survival (ESMO GROW)
Anja Thronicke, Patricia Grabowski, J.A.D.M. De Roos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3669-3669
Open Access
Anja Thronicke, Patricia Grabowski, J.A.D.M. De Roos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3669-3669
Open Access
Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis
Yin He, Xiaosheng Wang
Computers in Biology and Medicine (2023) Vol. 167, pp. 107591-107591
Closed Access | Times Cited: 10
Yin He, Xiaosheng Wang
Computers in Biology and Medicine (2023) Vol. 167, pp. 107591-107591
Closed Access | Times Cited: 10
Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies
Jibran Ahmed, Biswajit Das, Sarah J. Shin, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5841-5841
Open Access | Times Cited: 9
Jibran Ahmed, Biswajit Das, Sarah J. Shin, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5841-5841
Open Access | Times Cited: 9
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
Jie Yao, Xuwen Lin, Xin Zhang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Jie Yao, Xuwen Lin, Xin Zhang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-type Non-Small Cell Lung Cancer
Margaret Smith, Caroline B. Dixon, Yuezhu Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 23, pp. 4002-4016
Closed Access | Times Cited: 2
Margaret Smith, Caroline B. Dixon, Yuezhu Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 23, pp. 4002-4016
Closed Access | Times Cited: 2
Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis
Hang Yu, Qingquan Liu, Keting Wu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Hang Yu, Qingquan Liu, Keting Wu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer
Giedrė Gurevičienė, Jurgita Matulionė, Lina Poškienė, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 482-482
Open Access | Times Cited: 1
Giedrė Gurevičienė, Jurgita Matulionė, Lina Poškienė, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 482-482
Open Access | Times Cited: 1
Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacy
Christina Bruß, Veruschka Albert, Stephan Seitz, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Christina Bruß, Veruschka Albert, Stephan Seitz, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Molecular profiling of a bladder cancer with very high tumour mutational burden
Manuel Scimeca, Julia Bischof, Rita Bonfiglio, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Manuel Scimeca, Julia Bischof, Rita Bonfiglio, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
